Spleen-based islet transplantation restores glycemic control in type 1 diabetes without full immunosuppression

Wenzhou Medical University researchers have reimagined the spleen as a viable site for islet transplantation, enabling long-term diabetes control without the burden of full immunosuppression. Nanoparticle-driven spleen remodeling allowed transplanted mouse, rat, and human islets to restore normal blood sugar in diabetic rodents and cynomolgus macaques.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup